Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition. | Cancer Lett | 2023 | 37061119 | PubTator, text mining | PubMed |
| Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37058053 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification. | Int J Biol Sci | 2023 | 37056933 | PubTator, text mining | PubMed |
| Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma. | Am J Transl Res | 2023 | 37056835 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG15: A promising target in human cancers. | Front Oncol | 2023 | 37056344 | PubTator, text mining | PubMed |
| Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis. | Front Genet | 2023 | 37056286 | PubTator, text mining | PubMed |
| Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy. | Biomark Res | 2023 | 37055798 | PubTator, text mining | PubMed |
| Targeted Demethylation of the TGFβ1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway. | Cells | 2023 | 37048078 | PubTator, text mining | PubMed |
| Potential Roles of m6A and FTO in Synaptic Connectivity and Major Depressive Disorder. | Int J Mol Sci | 2023 | 37047192 | PubTator, text mining | PubMed |
| N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS). | J Ovarian Res | 2023 | 37046273 | PubTator, text mining | PubMed |
| m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy. | Sci Rep | 2023 | 37041267 | PubTator, text mining | PubMed |
| Evaluation of epitranscriptome-wide N6-methyladenosine differential analysis methods. | Brief Bioinform | 2023 | 37039682 | PubTator, text mining | PubMed |
| Vascular mimicry induced by m6A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma. | Cell Death Discov | 2023 | 37037853 | PubTator, text mining | PubMed |
| Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers. | Front Genet | 2023 | 37035750 | PubTator, text mining | PubMed |
| The m6A methylation landscape, molecular characterization and clinical relevance in prostate adenocarcinoma. | Front Immunol | 2023 | 37033963 | PubTator, text mining | PubMed |
| Cyr61 Mediates Angiotensin II-Induced Podocyte Apoptosis via the Upregulation of TXNIP. | J Immunol Res | 2023 | 37032654 | PubTator, text mining | PubMed |
| A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance. | Sci Rep | 2023 | 37031216 | PubTator, text mining | PubMed |
| METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity. | Protein Cell | 2023 | 37030005 | PubTator, text mining | PubMed |
| Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m6A-modified long non-coding RNAs in lung adenocarcinoma. | Clin Epigenetics | 2023 | 37029420 | PubTator, text mining | PubMed |
| VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. | J Biol Chem | 2023 | 37028765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=58